Benzodiazepines

I am still trying to reconcile what these chemicals are capable of, how the urge can morph into an action, how we maybe just don’t understand suicide all that well. For me, the suffering was so intense it was too painful to stay alive. I understand how my friends felt in their last moments.

After long-term use, most people are going to have serious symptoms when stopping SSRIs. Many people are going to have transient, mild to moderate difficulty and some are going to end up falling down the akathisia rabbit hole. That is a long, difficult drop.

A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.

Pictures are worth a thousand words. So I’ve chosen pictures to distill the mountain of mental health research I’ve examined over the last eight years. Three infographics summarize research on psychiatric drugs, and one asserts why I think Integrative Mental Health is the best path available for mental health recovery.

Long-term benzodiazepine use shown to effect cognitive function during current use and for years after drug discontinuation.

Oddly enough, it had occurred to me over this past year as I’ve been writing these essays for Mad in America that maybe I was “too healthy” to speak to the withdrawal experience with authenticity, to have street cred. It’s now a moot point. I write this not to scare people, but to present a reality. This reality has been difficult to accept, but the fact remains that my nervous system is more sensitive than before and might always be so, at least to some degree.

Many have asked: “Why doesn’t my doctor/provider know what is happening to me?” Benzodiazepine tolerance and withdrawal are not new. So, why isn’t it simple to diagnose and treat? As both a health care provider and a withdrawal sufferer, I’d like to offer an inside and outside perspective on this question.

Medically-induced harm—affecting tens of millions of people worldwide—has taken the field decades to take seriously.

My doctor insisted that my symptoms could not be associated with withdrawal – they had to be symptoms of an underlying condition. I have since learned from legitimate sources that protracted withdrawal syndrome from benzodiazepines can intensify long before it abates, with some symptoms lasting for years.

Prior use of benzodiazepines, such as Xanax, Librium, or Ativan, may increase the risk of treatment-resistant depression (TRD), according to a new study published in The Journal of Nervous and Mental Disease.

Can withdrawal from psychiatric drugging be so terrible as to leave you with Post-Traumatic Stress Disorder (PTSD) — to somehow rearrange your psyche for the worse even once time and hard work have undone the damage caused by the chemicals? To so profoundly alter your core self that you acquire a new diagnosis meriting special considerations or further treatment in order to resume a normal life again? If the real definition of insanity is “repeating the same mistake over and over and expecting a different result,” then embracing a psychiatric diagnosis of PTSD as a result of psychiatric damage would surely make you “insane”.

One size fits all does not work. It is not possible to use the same tapering schedule for all patients who wish to stop with a certain drug. Therefore we had to come up with a flexible solution that was both practical and allowed doctors and patients to make the choice they deemed appropriate.

Rock climber, author, and MIA Blogger Matt Samet discusses his experience becoming addicted to, and subsequently coming off of, benzodiazepines.

September 11^th 2015 was my last day working as a counselor/therapist in the U.S. community mental health system. After 22 years working within that system I resigned out of protest having waged a concerted effort (2½ years) to challenge potentially dangerous psychiatric drug prescribing patterns at my workplace. In late April of this year these challenges led to the filing of a major complaint with the Massachusetts Dept. of Mental Health and eventually the Dept. of Public Health. I never expected to discover just HOW unprepared, dysfunctional, and totally oblivious the entire state bureaucracy is when it involves any serious complaints detailing possible abuses and harm being done to its citizens by a branch of medicine called Psychiatry. Just how broken is "Broken"?

It is hard to believe that a year has gone past since I posted Playing the Odds: Antidepressant Withdrawal and the Problem of Informed Consent. The feedback I received underscored the more controversial aspects of SSRI toxicity.  Common themes concerned the abrupt onset of new symptoms 3 to 12 months after stopping the drug, reinstatement of the drug failing to help withdrawal related symptoms, the possibility that withdrawal-related symptoms can persist indefinitely and concerns about using benzodiazepines to help with tardive akathisia.

Benzodiazepine medications that are commonly used for calming or sedating people can sometimes apparently cause violent or aggressive responses in some people, according to...

While any effort to generate awareness and potentially curb the benzodiazepine epidemic is commendable, we have to ask ourselves, is Xanax just the scapegoat in this situation? Will legislative action and media attention for only one benzodiazepine out of so many make any difference?

Three out of four users of the sedative, zolpidem (brand name Ambien), do not follow FDA recommendations to reduce risk.

A new special issue brings together articles exploring the harmful effects of simultaneous multiple medication use.

H. 3594 would require pharmacists to distribute pamphlets containing information on benzodiazepine misuse and abuse, risk of dependency and addiction, handling and addiction treatment resources. This would be a major legislative response to the prescribing patterns for these drugs today.

When the benzodiazepines were first introduced, it was widely claimed, both by psychiatrists and by pharma, that they were non-addictive. This claim was subsequently abandoned in the face of overwhelming evidence to the contrary, and the addictive potential of these products is now recognized and generally accepted.

Two years ago, when I first felt the dizzy confusion of benzo disability, I talked about it openly. I remember discussing it briefly with an older friend who found my plight strangely fascinating. He asked if I remembered Quaaludes, a sedative-hypnotic that was all the rage in the 1960s and ‘70s. “We called them ‘Stumble Biscuits,’” he told me, “because you’d stumble down the street and hit one car and then stumble over and hit something else and it was just happy and goofy. It’s too bad they took them off the market. Those things were great.”

In commemoration of World Benzodiazepine Awareness Day coming on July 11th, I am providing an early first time debut at Mad in America of a new song and music video titled “Benzo Blue,” along with a brief commentary on the evolution and significance of this song.

"My studies in this area lead me to a very uncomfortable conclusion: Our citizens would be far better off if we removed all the psychotropic drugs from the market, as doctors are unable to handle them. It is inescapable that their availability creates more harm than good." - Peter Gøtzsche, MD; Co-founder of the Cochrane Collaboration

The U.S. Food and Drug Administration yesterday mandated updated labels for nearly 400 opioids and benzodiazepines, following a review of scientific evidence and a citizen...